In our study, when compared to mice treated only with anti-CTLA-4 or lycorine hydrochloride therapy, mice on the combination treatment regimen showed significantly reduced orthotopic and metastatic tumors (Figure 4). The gene discussed is CTLA4; the disease is metastatic neoplasm.